Feghali Bostwick Lab

Feghali-Bostwick Translational Research Lab

Carol Feghali-Bostwick, Ph.D.Carol Feghali-Bostwick, Ph.D.

Professor and SmartState and Kitty Trask Holt Endowed Chair for Scleroderma Research
Division of Rheumatology & Immunology

 

Carol Feghali-Bostwick, Ph.D., was recruited to the Division of Rheumatology and Immunology in 2013 as the SmartState and Kitty Trask Holt Endowed Chair and Professor of Medicine. Dr. Feghali-Bostwick earned her Ph.D. in Microbiology and Immunology at Tulane University in New Orleans, LA. Dr. Feghali-Bostwick leads a team of clinical and basic scientists focusing on the pathogenic mechanisms underlying fibrosis whose goal is to identify novel targets for therapy and develop new anti-fibrotic strategies for scleroderma/systemic sclerosis, idiopathic pulmonary fibrosis, and other fibrosing conditions. Dr. Feghali-Bostwick also contributes to the mentoring of young physician and academic scientists.

Work in the Feghali-Bostwick laboratory has been supported by grants from the NIH, NIAMS and NHLBI, the SmartState SC Centers of Economic Excellence, the Kitty Trask Holt fund, and the Merdie Shoemaker Scleroderma Research Fund.

Publications:

PubMed Collection

Senior Author Publications:

Senior Author PubMed Collection (senior author publications are most often associated with mentored projects)